Remembrane is proud to announce a new technological partnership with SynAging SAS, showing once more its commitment to improving and offering ultimate solutions for your research projects. SynAging is a french contract research organization (CRO) that focuses on toxic oligomeric protein assemblies, which are involved in the earliest stages of age-related neurodegenerative diseases. For more information, visit www.synaging.com.